共 30 条
[11]
Chirgwin JM, Przybyla AE, Mcdonald RJ, Et al., Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease, Biochemistry, 18, (1979)
[12]
Brenner CA, Tam AW, Nelson PA, Message amplification phenotyping (MAPPing): A technique to simultaneously measure multiple mRNAs from small numbers of cells, BioTechniques, 7, (1989)
[13]
Edmunds LH, Why cardiopulmonary bypass makes patients sick: Strategies to control the blood‐surface interface, Advances in Cardiac Surgery, 6, pp. 131-167, (1995)
[14]
Downing SW, Edmunds LH, Release of vasoactive substances during cardiopulmonary bypass, Ann Thor Surg, 54, pp. 1236-1243, (1992)
[15]
Jansen NJG, van Oeveren W, van der Brock, Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass, J Thorac Cardiovasc Surg, 102, pp. 515-525, (1991)
[16]
Ognibene FP, Rosenberg SA, Lotze MT, Et al., Interleukin‐2 administration causes reversible hemodynamic changes and left ventricular dysfunction similar to those seen in septic shock, Chest, 94, pp. 750-754, (1988)
[17]
Gulick T, Chung MK, Peiper SJ, Et al., Interleukin‐1 and tumor necrosis factor inhibit cardiac myocyte B‐adrenergic responsiveness, Proc Natl Acad Sci USA, 86, pp. 6753-6757, (1989)
[18]
Mehta JL, Nichols WW, Mehta P, Neutrophils as potential participants in acute myocardial ischemia: Relevance to reperfusion, J Am Coll Cardiol, 11, pp. 1309-1316, (1988)
[19]
Pober JS, Bevilacqua MP, Mendrick DL, Et al., Two distinct cytokines, interleukin‐1 and tumor necrosis factor, each independently induces biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells, J Immunol, 136, pp. 1680-1687, (1986)
[20]
Gorcsan J, Gasior TA, Mandarino WA, Et al., Assessment of the immediate effects of cardiopulmonary bypass on ventricular performance using real time pressure‐area relations, Circulation, 89, pp. 180-190, (1994)